PharVision Advisers’s Vail Resorts MTN Stock Holding History

PharVision Advisers’s Portfolio MTN Stock Details MTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,497	Closed	-$597K	–	447
2025 Q4	$597K	Buy	4,497 +2,896	+181%	+$426K	0.3%	15
2025 Q3	$239K	Buy	+1,601	New	+$248K	0.13%	363
2025 Q2	–	Sell	-1,770	Closed	-$283K	–	373
2025 Q1	$283K	Buy	+1,770	New	+$294K	0.39%	103

Other funds holding MTN

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PharVision Advisers's MTN Position: Q1 2026 in Review

PharVision Advisers sold out of Vail Resorts (MTN) in Q1 2026, closing a stake of 4,497 shares — an estimated $597K sold.

PharVision Advisers first reported a position in MTN in Q1 2025 and held it in 3 quarters. The position peaked at $597K in Q4 2025. 442 funds tracked by Wall St. Rank hold MTN as of Q1 2026.

PharVision Advisers reported no remaining Vail Resorts position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 4,497 Vail Resorts shares in Q1 2026, an estimated $597K.
PharVision Advisers first reported a position in Vail Resorts in Q1 2025 and held it in 3 quarters.
PharVision Advisers's Vail Resorts position peaked at $597K in Q4 2025.
442 funds tracked by Wall St. Rank held Vail Resorts as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.